Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth.
暂无分享,去创建一个
M. Aoki | T. Ogihara | Y. Kaneda | R. Morishita | J. Higaki | Motokuni Aoki | H. Nakagami | A. Moriguchi | T Ogihara | S Hayashi | Y Kaneda | S. Hayashi | J Higaki | M Aoki | R Morishita | H Matsushita | H Nakagami | K Yamamoto | K. Yamamoto | A Moriguchi | H. Matsushita | Kei Yamamoto | H. Nakagami | T. Ogihara | Shin-ichiro Hayashi | Y. Kaneda | J. Higaki
[1] M. Horiuchi,et al. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. , 1996, Circulation research.
[2] W. Kaelin,et al. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] F. Lanza,et al. The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis. , 1994, Cancer research.
[4] G. Kou,et al. Human Cytomegalovirus Immediate-Early Protein IE2 Tethers a Transcriptional Repression Domain to p53 (*) , 1996, The Journal of Biological Chemistry.
[5] P. Libby,et al. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.
[6] Y. Goda,et al. The mutagenic constituents of Rubia tinctorum. , 1992, Chemical & pharmaceutical bulletin.
[7] H. Kamiya,et al. Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen. , 1995, Cellular immunology.
[8] T. Ogihara,et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Desmoulière,et al. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. , 1995, The American journal of pathology.
[10] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[11] J. Parsonnet,et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. , 1997, The New England journal of medicine.
[12] Bert Vogelstein,et al. p53 function and dysfunction , 1992, Cell.
[13] T. Ogihara,et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. , 1994, The Journal of clinical investigation.
[14] M. Aoki,et al. Serum deprivation-induced apoptosis accompanied by up-regulation of p53 and bax in human aortic vascular smooth muscle cells. , 1997, Heart and vessels.
[15] G. Evan,et al. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.
[16] M. Bennett,et al. Plaques Senescence , and Apoptosis in Human Vascular Smooth Muscle Cells From Atherosclerotic Cooperative Interactions Between RB and p 53 Regulate Cell Proliferation , Cell , 1998 .
[17] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.
[18] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[19] J. Isner,et al. Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.
[20] Peter J. Smith. Earthquakes without precursors? , 1975, Nature.
[21] G. Evan,et al. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. , 1995, Circulation research.
[22] P. Libby,et al. Culture of quiescent arterial smooth muscle cells in a defined serum‐free medium , 1983, Journal of cellular physiology.
[23] T. Ogihara,et al. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. , 1994, The Journal of clinical investigation.
[24] John Calvin Reed,et al. Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.
[25] S. Weintraub,et al. Retinoblastoma protein switches the E2F site from positive to negative element , 1992, Nature.
[26] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[27] G. Evan,et al. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. , 1994, Circulation research.
[28] John Calvin Reed. Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.
[29] M. Leon,et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.
[30] M. Leon,et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.
[31] D. Lane,et al. p53, guardian of the genome , 1992, Nature.
[32] G. Gibbons,et al. The emerging concept of vascular remodeling. , 1994, The New England journal of medicine.
[33] J. Hatzfeld,et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides , 1991, The Journal of experimental medicine.
[34] S. Lowe,et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.
[35] R. DePinho,et al. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.
[36] P. Bonin,et al. Growth factor-induced modulation of endothelin-1 binding to human smooth-muscle cells. , 1993, Journal of cardiovascular pharmacology.
[37] J. Seltzer,et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product , 1995, Science.
[38] T. Ogihara,et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] B L Langille,et al. Apoptosis (programmed cell death) in arteries of the neonatal lamb. , 1995, Circulation research.
[40] M. Ishiyama,et al. A New Sulfonated Tetrazolium Salt That Produces a Highly Water-Soluble Formazan Dye , 1993 .